chevron_leftBack
As of 24 April 2025, Yifan Pharmaceutical Co., Ltd. has a market cap of $1.89B USD, ranking #5559 globally and #1251 in China. It ranks #508 in the Healthcare sector, and #37 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.89BUSD
13.75B CNY
Enterprise Value
$2.07BUSD
15.08B CNY
Revenue (TTM)
$685.61MUSD
5.0B CNY
EBITDA (TTM)
$58.72MUSD
427.9M CNY
Net Income (TTM)
-$45.5MUSD
-331.54M CNY
EBITDA Margin
8.6%
Profit Margin
-6.6%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Xian Feng Cheng
open_in_new
Employees
4,230
Founded
2000
Website
yifanyy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.7% | 3.2% | -1.7% | 9.2% | -6.5% | -0.4% |
Upcoming Earnings
Earnings Date
Mon, Apr 28
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002019
亿帆医药股份有限公司 Class A
ISIN: CNE000001K65
Shares Out.:
Shares Outstanding:
1.216B1
Shares Float:
1.004B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
11.31 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yifan Pharmaceutical Co., Ltd.
Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinology/metabolic, dermatological, gynecologic, and pediatric diseases, etc. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
